Helen L. Collins,James Hnatyszyn,Hong Xiang,Xiang Zhang
申请号：
US16613579
公开号：
US20200079856A1
申请日:
2018.05.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This application relates to uses of antibodies against fibroblast growth factor receptor 2 (FGFR2), including antibodies against the FGFR2 isoform FGFR2-IIIb (also known as FGFR2b), in treatment of certain cancers in combinations with mFOLFOX6 chemotherapy.
